person

Phil Jones

British cancer biologist, a Fellow of the Royal Society, professor of cancer development at the University of Cambridge and a senior group leader at the Wellcome Sanger Institute. His work concerns how mutant cell clones compete in normal epithelial tissue.

Known aliases

Philip Jones
Phil Jones FRS

Relationships

No evidence-backed relationships are recorded.

Current clusters

science1 publisher

Chemoradiotherapy reshapes which mutant clones win in the normal esophagus

Sanger Institute researchers sequenced healthy esophageal lining from 70 patients treated for esophageal cancer and found that a few weeks of chemoradiotherapy left significantly more normal cells carrying cancer-related mutations.

Publishers:genengnews.com

Reality

Evidence66
Adoption: Insufficient
Hype gap+12
Incentives46
Confidence55